Can Fite Biofarma Ltd (CANF)
1.97
-0.04
(-1.99%)
USD |
NYAM |
Nov 21, 16:00
2.00
+0.03
(+1.52%)
After-Hours: 20:00
Can Fite Biofarma Max Drawdown (5Y): 99.32% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.32% |
| September 30, 2024 | 99.32% |
| August 31, 2024 | 99.32% |
| July 31, 2024 | 99.32% |
| June 30, 2024 | 99.32% |
| May 31, 2024 | 99.32% |
| April 30, 2024 | 99.32% |
| March 31, 2024 | 99.32% |
| February 29, 2024 | 99.32% |
| January 31, 2024 | 99.32% |
| December 31, 2023 | 99.32% |
| November 30, 2023 | 99.32% |
| October 31, 2023 | 99.32% |
| September 30, 2023 | 99.32% |
| August 31, 2023 | 99.32% |
| July 31, 2023 | 99.32% |
| June 30, 2023 | 99.32% |
| May 31, 2023 | 99.32% |
| April 30, 2023 | 99.32% |
| March 31, 2023 | 99.11% |
| February 28, 2023 | 99.11% |
| January 31, 2023 | 98.95% |
| December 31, 2022 | 98.63% |
| November 30, 2022 | 98.63% |
| October 31, 2022 | 98.63% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.63% |
| August 31, 2022 | 98.63% |
| July 31, 2022 | 98.63% |
| June 30, 2022 | 98.63% |
| May 31, 2022 | 98.63% |
| April 30, 2022 | 98.63% |
| March 31, 2022 | 98.63% |
| February 28, 2022 | 98.63% |
| January 31, 2022 | 98.63% |
| December 31, 2021 | 98.63% |
| November 30, 2021 | 98.63% |
| October 31, 2021 | 98.63% |
| September 30, 2021 | 98.63% |
| August 31, 2021 | 98.63% |
| July 31, 2021 | 98.63% |
| June 30, 2021 | 98.63% |
| May 31, 2021 | 98.63% |
| April 30, 2021 | 98.63% |
| March 31, 2021 | 98.63% |
| February 28, 2021 | 98.63% |
| January 31, 2021 | 98.63% |
| December 31, 2020 | 98.63% |
| November 30, 2020 | 98.63% |
| October 31, 2020 | 98.63% |
| September 30, 2020 | 98.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.64%
Minimum
Nov 2019
99.32%
Maximum
Apr 2023
98.82%
Average
98.63%
Median
Feb 2020
Max Drawdown (5Y) Benchmarks
| Compugen Ltd | 97.28% |
| Pluri Inc | 96.65% |
| BioLine Rx Ltd | 97.41% |
| XTL Biopharmaceuticals Ltd | 92.62% |
| BiomX Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -58.63 |
| Beta (5Y) | 1.386 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 65.14% |
| Historical Sharpe Ratio (5Y) | -0.6255 |
| Historical Sortino (5Y) | -1.015 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.73% |